BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) saw a large drop in short interest in the month of September. As of September 30th, there was short interest totaling 6,488 shares, a drop of 41.5% from the September 15th total of 11,096 shares. Based on an average daily volume of 2,045 shares, the days-to-cover ratio is currently 3.2 days.
BioSyent Price Performance
BIOYF stock remained flat at $11.00 during trading on Thursday. 6,845 shares of the company traded hands, compared to its average volume of 2,446. The stock’s 50-day moving average price is $11.36 and its two-hundred day moving average price is $10.72. BioSyent has a 12 month low of $7.63 and a 12 month high of $12.45.
About BioSyent
BioSyent Inc is a Canadian specialty pharmaceutical company focused on acquiring, licensing, developing and commercializing healthcare products, primarily for the Canadian market. Through its operating businesses, the company markets prescription and over-the-counter products in selected therapeutic areas.
BioSyent’s product portfolio has included FeraMAX, an iron replacement product available in several formulations, as well as other products serving areas such as women’s health, gastroenterology and hospital care.
See Also
- Five stocks we like better than BioSyent
- Synopsys Signals Confidence With $1B Accelerated Buyback, Analysts Raise Targets
- Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But Up
- Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?
- Failed Breakout in Tech? 3 Sectors Leading the Market Rotation
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
